Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,893,520 papers from all fields of science
Search
Sign In
Create Free Account
buflomedil
Known as:
2,4,6-trimethoxyphenyl-3-pyrrolidine propyl ketone
, blufomedil
, 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Narrower (5)
Buflomedil Lindo
Fonzylane
Loftyl
buflomedil hydrochloride
Expand
Broader (2)
Pyrrolidines
Vasodilator Agents
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Lactate is an ideal non-invasive marker for evaluating temporal alterations in cell stress and toxicity in repeat dose testing regimes.
A. Limonciel
,
L. Aschauer
,
+4 authors
P. Jennings
Toxicology in Vitro
2011
Corpus ID: 205411476
Review
2008
Review
2008
Buflomedil for intermittent claudication.
T. D. de Backer
,
M. Bogaert
,
R. V. Vander Stichele
Cochrane Database of Systematic Reviews
2008
Corpus ID: 23588792
BACKGROUND Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during…
Expand
Highly Cited
2007
Highly Cited
2007
Long-Term Follow-Up of Hypothenar Hammer Syndrome: A Series of 47 Patients
I. Marie
,
F. Hervé
,
E. Primard
,
N. Cailleux
,
H. Lévesque
Medicine
2007
Corpus ID: 34195085
Hypothenar hammer syndrome (HHS) is an uncommon form of secondary Raynaud phenomenon, occurring mainly in subjects who use the…
Expand
Highly Cited
2005
Highly Cited
2005
Continuous Peripheral Nerve Blocks at Home for Treatment of Recurrent Complex Regional Pain Syndrome I in Children
C. Dadure
,
Frédéric Motais
,
C. Ricard
,
O. Raux
,
R. Troncin
,
X. Capdevila
Anesthesiology
2005
Corpus ID: 10846619
Background:Recurrent complex regional pain syndrome I is not rare in the pediatric population. The authors conducted this study…
Expand
Highly Cited
2001
Highly Cited
2001
Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate.
R. Bettini
,
P. Catellani
,
P. Santi
,
G. Massimo
,
N. Peppas
,
P. Colombo
Journal of Controlled Release
2001
Corpus ID: 13929586
Highly Cited
1995
Highly Cited
1995
Drug diffusion front movement is important in drug release control from swellable matrix tablets.
P. Colombo
,
R. Bettini
,
G. Massimo
,
P. Catellani
,
P. Santi
,
N. Peppas
Journal of Pharmacy and Science
1995
Corpus ID: 25922560
Swellable controlled release devices of buflomedil pyridoxalphosphate in hydroxypropyl methylcellulose were prepared, and their…
Expand
1991
1991
Increase in Skin‐Flap Survival by the Vasoactive Drug Buflomedil
T. Galla
,
Rainer K. -E. Saetzler
,
F. Hammersen
,
K. Messmer
Plastic and Reconstructive Surgery
1991
Corpus ID: 21312764
The effect of buflomedil to protect skin tissue from ischemia and necrosis was studied in random cutaneous flaps. Measurements…
Expand
1984
1984
Buflomedil in Arterial Occlusive Disease: Results of a Controlled Multicenter Study
G. Trübestein
,
K. Balzer
,
+5 authors
W. Ziegler
Angiology
1984
Corpus ID: 29585186
In a double-blind, randomised multicentre study buflomedil, a vasoactive substance, was compared with placebo in the treatment of…
Expand
Review
1981
Review
1981
An Experimental Overview of a New Vasoactive Drug: Buflomedil HCl
A. Dubourg
,
R. Scamuffa
Angiology
1981
Corpus ID: 37471654
A brief review of the pharmacology, pharmacokinetics, and metabolism of buf lomedil-HCl is presented providing a phar macologic…
Expand
1981
1981
Effects of Buflomedil on Erythrocyte Deformability
J. Dormandy
,
E. Ernst
Angiology
1981
Corpus ID: 38026751
This brief communication outlines re cent experiments on the effects of buflo medil, a new vasoactive agent, on red cell…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE